logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11999777 B1

PDFFull Text
Date of Patent:
Jun. 04, 2024

Filed:

Jun. 02, 2021

Methods for treating or preventing sars-cov-2 infections and covid-19 with anti-sars-cov-2 spike glycoprotein antibodies

Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Samit Ganguly, Elmsford, NY (US);

Jennifer Hamilton, Ridgefield, CT (US);

Gary Herman, Princeton, NJ (US);

Andrea Hooper, Port Chester, NY (US);

Flonza Isa, Yonkers, NY (US);

Meagan O'Brien, New York, NY (US);

Sumathi Sivapalasingam, Brooklyn, NY (US);

Kenneth Turner, Ridgefield, CT (US);

Eduardo Forleo Neto, Greenwich, CT (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:

Schwabe, Williamson & Wyatt PC

Gabe Amodeo

Primary Examiner:

Aurora M Fontainhas

Assistant Examiner:

Jennifer A Benavides

Int. Cl.
CPC ...
C07K 16/10 (2006.01); A61K 9/00 (2006.01); A61K 31/706 (2006.01); A61K 39/42 (2006.01); A61K 45/06 (2006.01); A61P 31/14 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/10 (2013.01); A61K 9/0019 (2013.01); A61K 31/706 (2013.01); A61K 39/42 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01); C07K 16/2866 (2013.01); A61K 2039/507 (2013.01); A61K 2039/54 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract

The present invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods of the invention feature the administration of one or more antigen-binding molecules (e.g., antibodies) that bind a surface protein of SARS-CoV-2 (e.g., spike protein).

Find Patent Forward Citations

Ganguly, Samit. (2024). Methods for treating or preventing sars-cov-2 infections and covid-19 with anti-sars-cov-2 spike glycoprotein antibodies (U.S. Patent No. 11999777). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11999777

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…